Clinical Trial Update: Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update on the use of Tenofovir DF in adolescents with chronic hepatitis B, terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir DF (tenofovir alafenamide or tenofovir disoproxil fumarate?)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis B | Phase 4 | Status: TERMINATED | Results posted: 2019-05-20